Axtria, a global provider of AI-first data analytics solutions for the life sciences industry, announced the acquisition of Conexus Solutions, a technology and managed services partner specializing in CRM transformation across the Veeva and Salesforce ecosystems.
The transaction marks Axtria’s entry into end-to-end CRM capabilities, combining its agentic AI platform with Conexus’ expertise in CRM execution. The combined offering is designed to unify systems of engagement with systems of intelligence, spanning data infrastructure, field execution, and patient outcomes.
The acquisition comes at a time when life sciences organizations are navigating structural shifts across commercial, quality, and R&D operations. Industry pressures including patent expirations, the rise of specialty and cell-and-gene therapies, and increasing demands from payers for outcomes-based evidence are reshaping how companies engage with patients and providers. CRM platforms remain central to these efforts but have traditionally functioned as transactional systems rather than intelligence-driven engines.
By integrating Conexus’ CRM capabilities with Axtria’s AI-driven platforms, including Axtria SalesIQ, CustomerIQ, MarketingIQ, and DataMAx, the combined company aims to deliver a unified, AI-native commercialization stack. This includes capabilities across sales planning, data optimization, next-best-action insights, and enterprise orchestration.
Conexus brings domain expertise across commercial, quality, and R&D operations, along with a certified talent base and established partnerships within the Veeva and Salesforce ecosystems. The combination is intended to provide life sciences companies with an integrated approach to customer engagement and operational execution.
Axtria indicated that existing clients of both companies will continue to receive the same level of service, while gaining access to expanded capabilities over time. The company also emphasized that Conexus’ client-centric culture and delivery model will be preserved and enhanced as part of the integration.
The acquisition reflects a broader industry shift toward consolidating fragmented technology stacks into unified platforms that can translate data-driven insights into real-time actions. Axtria and Conexus aim to address longstanding challenges in connecting analytics with frontline execution, particularly in highly regulated and data-intensive life sciences environments.
KEY QUOTES:
“This acquisition is a highly strategic step in Axtria’s journey to build the most comprehensive AI-driven commercial platform for life sciences. Conexus brings exceptional CRM expertise, deep customer relationships, and a talented team that complement our capabilities perfectly. Together, we are uniquely positioned to bridge systems of engagement with systems of intelligence, delivering integrated, outcome-driven solutions to our clients,”
Jassi Chadha, President And CEO, Axtria
“Joining Axtria is an exciting next step for Conexus. Our shared commitment to customer success, innovation, and life sciences expertise makes this a natural and powerful combination. Our clients will continue to receive the same trusted service while gaining access to Axtria’s broader capabilities over time,”
Akshay Kapadia, Founder And CEO, Conexus Solutions
